Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001485003-22-000043
Filing Date
2022-04-12
Accepted
2022-04-12 16:31:26
Documents
5
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 PRE 14A sesn2022preliminaryproxyst.htm PRE 14A 540308
2 image.jpg GRAPHIC 6288
3 logoa05.jpg GRAPHIC 7341
4 proxycard1finalpre14-jpega.jpg GRAPHIC 162995
5 proxycard2finalpre14-jpega.jpg GRAPHIC 118957
  Complete submission text file 0001485003-22-000043.txt   948928
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36296 | Film No.: 22822637
SIC: 2834 Pharmaceutical Preparations